George V Migausky insider trades: Immunovant (IMVT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where George reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | IMVT | ↓ Sell | 12,700 | $39.73 | $505K | Direct | Dec 5, 2023 (4d) |
| Aug 20, 2021 | IMVT | ↑ Buy | 7,000 | $7.65 | $54K | Direct | Aug 20, 2021 (0d) |
| Aug 17, 2015 | DYAX | ↓ Sell | 116,000 | $22.85 | $2.7M | Direct | Aug 19, 2015 (2d) |
| Aug 17, 2015 | DYAX | ↓ Sell | 9,000 | $22.84 | $206K | By Trust | Aug 19, 2015 (2d) |
| Mar 5, 2015 | DYAX | ↓ Sell | 5,000 | $15.86 | $79K | Direct | Mar 6, 2015 (1d) |
| Feb 24, 2015 | DYAX | ↓ Sell | 9,000 | $15.64 | $141K | Direct | Feb 26, 2015 (2d) |
| Jun 13, 2014 | DYAX | ↓ Sell | 10,000 | $8.27 | $83K | Direct | Jun 17, 2014 (4d) |
| Jun 13, 2014 | DYAX | ↓ Sell | 6,000 | $8.25 | $50K | By Trust | Jun 17, 2014 (4d) |
| Feb 24, 2014 | DYAX | ↓ Sell | 11,875 | $10.37 | $123K | Direct | Feb 26, 2014 (2d) |
| Feb 25, 2013 | DYAX | ↓ Sell | 4,275 | $3.28 | $14K | Direct | Feb 27, 2013 (2d) |
| Aug 8, 2011 | DYAX | ↑ Buy | 6,000 | $1.34 | $8K | By trusts | Aug 9, 2011 (1d) |
| Aug 8, 2011 | DYAX | ↑ Buy | 4,000 | $1.34 | $5K | Direct | Aug 9, 2011 (1d) |
| Mar 11, 2011 | DYAX | ↑ Buy | 6,000 | $1.52 | $9K | By trusts | Mar 14, 2011 (3d) |
| Mar 11, 2011 | DYAX | ↑ Buy | 5,000 | $1.52 | $8K | Direct | Mar 14, 2011 (3d) |
| Aug 24, 2010 | DYAX | ↑ Buy | 9,000 | $2.15 | $19K | By trusts | Aug 25, 2010 (1d) |
| Aug 24, 2010 | DYAX | ↑ Buy | 3,000 | $2.15 | $6K | Direct | Aug 25, 2010 (1d) |
| May 27, 2010 | DYAX | ↑ Buy | 6,000 | $2.49 | $15K | Direct | May 27, 2010 (0d) |
| Jun 15, 2009 | DYAX | ↑ Buy | 6,000 | $2.01 | $12K | Direct | Jun 16, 2009 (1d) |
| Jun 15, 2009 | DYAX | ↑ Buy | 3,000 | $2.01 | $6K | By minor child | Jun 16, 2009 (1d) |
| Nov 26, 2008 | DYAX | ↑ Buy | 16,000 | $2.48 | $40K | Direct | Dec 1, 2008 (5d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMVT insiders
Open-market trades in the last 12 months
About George V Migausky's insider trades
George V Migausky is a director at Immunovant (IMVT). Since Nov 26, 2008, George has reported 11 open-market purchases worth $182K and 9 sales worth $3.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (29 filings), shares returned to the company (4 filings), option exercises (4 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMVT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.